Patients With Low Platelets Counts
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patients With Low Platelets Counts trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patients With Low Platelets Counts trials you may qualify forThe purpose of this study is to see if the study drug, romiplostim, helps low platelet count caused by standard chemotherapy treatment for lymphoma. This study…
1. Investigate the role of thromboelastometry (ROTEM) parameters in the prediction of bleeding events in thrombocytopenic patients. 2. Interpretation of platele…
This phase II trial studies how well romiplostim works in increasing low platelet counts in patients with multiple myeloma receiving chemotherapy. Romiplostim m…
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic cancer. PURPOSE: Phase II trial to study the effectiveness of cyclosporine in treati…
The purpose of this study is to investigate the efficacy, safety and tolerability of eltrombopag in children with previously treated chronic immune thrombocytop…